1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA AC006486.9 CTRPv2 pan-cancer AAC 0.15 6e-06
mRNA AC007906.1 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA AC009133.22 CTRPv2 pan-cancer AAC -0.13 0.0001
mRNA AC009133.23 CTRPv2 pan-cancer AAC 0.12 0.0002
mRNA AC009336.19 CTRPv2 pan-cancer AAC 0.13 0.0002
mRNA AC027682.1 CTRPv2 pan-cancer AAC -0.11 0.0008
mRNA AC090094.1 CTRPv2 pan-cancer AAC -0.17 4e-06
mRNA AC092835.2 CTRPv2 pan-cancer AAC 0.13 0.0001
mRNA AC104534.3 CTRPv2 pan-cancer AAC 0.15 9e-06
mRNA AC104581.1 CTRPv2 pan-cancer AAC 0.13 3e-05
Download CSV